Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff J Guo

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
American Health & Drug Benefits|July 4, 2014
Recent developments, utilization, and spending trends for pompe disease therapiesJing Guo, Christina M L Kelton, Jeff J Guo
Pharmacotherapy|October 7, 2005
Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virusJeff J Guo, Raymond Jang, Anthony Louder, et al.
Pharmacy Practice|September 13, 2014
Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysisYan Chen, Jeff J Guo, Daniel P Healy, et al.
The Annals of Pharmacotherapy|November 23, 2006
Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysisYan Chen, Jeff J Guo, Siyan Zhan, et al.
International Clinical Psychopharmacology|April 7, 2007
Antidepressant prophylaxis for poststroke depression: a meta-analysisYan Chen, Nick C Patel, Jeff J Guo, et al.
Leukemia & Lymphoma|November 15, 2021
Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United StatesXiaomeng Yue, Ana L Hincapie, Yuxiang Li, et al.
Intractable & Rare Diseases Research|December 8, 2021
Off-label medication use in rare pediatric diseases in the United StatesAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Intractable & Rare Diseases Research|September 4, 2025
Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settingsAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Comparison of potentially hepatotoxic drugs among major US drug compendiaJeff J Guo, Patricia R Wigle, Kangsan Lammers, et al.
Exploratory Research in Clinical and Social Pharmacy|December 25, 2023
Utilization, reimbursement, and price trends for Hepatitis C virus medications in the US Medicaid programs: 2001-2021Musaab H Gari, Abdulrahman Alsuhibani, Amin Alashgar, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
American Health & Drug Benefits|July 4, 2014
Recent developments, utilization, and spending trends for pompe disease therapiesJing Guo, Christina M L Kelton, Jeff J Guo
Pharmacotherapy|October 7, 2005
Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virusJeff J Guo, Raymond Jang, Anthony Louder, et al.
Pharmacy Practice|September 13, 2014
Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysisYan Chen, Jeff J Guo, Daniel P Healy, et al.
The Annals of Pharmacotherapy|November 23, 2006
Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysisYan Chen, Jeff J Guo, Siyan Zhan, et al.
International Clinical Psychopharmacology|April 7, 2007
Antidepressant prophylaxis for poststroke depression: a meta-analysisYan Chen, Nick C Patel, Jeff J Guo, et al.
Leukemia & Lymphoma|November 15, 2021
Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United StatesXiaomeng Yue, Ana L Hincapie, Yuxiang Li, et al.
Intractable & Rare Diseases Research|December 8, 2021
Off-label medication use in rare pediatric diseases in the United StatesAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Intractable & Rare Diseases Research|September 4, 2025
Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settingsAlbert Fung, Xiaomeng Yue, Patricia R Wigle, et al.
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Comparison of potentially hepatotoxic drugs among major US drug compendiaJeff J Guo, Patricia R Wigle, Kangsan Lammers, et al.
Exploratory Research in Clinical and Social Pharmacy|December 25, 2023
Utilization, reimbursement, and price trends for Hepatitis C virus medications in the US Medicaid programs: 2001-2021Musaab H Gari, Abdulrahman Alsuhibani, Amin Alashgar, et al.
Pageof 8